In the year 1919, Karl Ereky coined the term ‘biotechnology’ to describe the merging of biology and technology. Biotechnology at its simplest can be described as using technology that harnesses cellular and bimolecular processes for the improvement of our life as well as the planet’s.
People have been harnessing biotechnology for more than thousands of years for making bread, alcoholic beverages and cheese and preserving dairy products. But such applications are not what biotechnology is meant by today. For more than a decade now the biotechnology industry was dominated by recombinant DNA technology and genetic engineering. Right now biotechnology has spread vastly over some sciences such as genomics, recombinant gene techniques, applied immunology, genetic engineering, cell and tissue culture technologies and development of pharmaceuticals therapies and diagnostics tests. In addition to the application mentioned above, biotechnology also involves merging biological information with computer technology and also applying the use of stem cell research and cloning to replace dead or defective cells effectively. In addition to healthcare, biotechnology has also proved helpful is refining the industrial process through the discovery and production of biological enzymes that speaks chemical reaction that are used for environmental cleanup and in agricultural production through genetic engineering. Biotechnology has its roots embedded in the agricultural industry too. Farmers make use of biotechnology by production of generally modified crops, the DNA of which crops has been modified with the use of genetic engineering techniques. These certain kinds of crops include perks such as resistance pests, diseases, resistance to chemical treatments and certain stressful environmental conditions. In this manner biotechnology branches out to nearly all application and industries given proper research and resources. We at MIR believe in harnessing our knowledge to the fullest in the hopes of giving our clients the most exclusive analytical reports. Our reports contains the latest in biotechnological advancements along with detailed forecasts for years to come giving our clients the edge that they need in order to put them ahead of the field.
Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering & Genetic Engineering), End User (Research Centers, Pharmaceutical & Biotechnology Companies, CROs) - Analysis & Forecast 2019-2030
Genome Editing/Genome Engineering Market Overview and Introduction
The global genome editing market was valued at over US$ 3.0 Bn. in 2017 and is anticipated to grow at a CAGR of 14.1% from 2019 to 2030.The global genome editing/genome engineering market is segmented by application, technology, end user, and region.
Genome Editing/Genome Engineering technique are used for insertion, deletion or modify genome of a microorganism. Techniques like TALEN, CRI... Read more
Published :Apr 2020 | Pages : 150 | Price starts from : $5100